TearLab Osmolarity System
Device Diagnostics
General payments
$314,432
Research payments
$0
Through program year 2023, $314,432 in general payments and $0 in research payments were reported against TearLab Osmolarity System (Diagnostics).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | General | $136,109 | 471 |
| 2022 | General | $80,284 | 243 |
| 2021 | General | $46,678 | 300 |
| 2020 | General | $20,291 | 62 |
| 2019 | General | $31,071 | 187 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2023.
The top 5 of 11 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.
The top 5 of 37 states; each share is of general payments naming this product in 2023 where a state was reported.
Records
1,263 generalEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.